SPOTLIGHT: Up to 100,000 Vioxx claims expected
A federal judge in New Orleans told a gathering of attorneys that there could be as many as 100,000 Vioxx claims when all is said and done. More than 2,000 cases have been filed so far and analysts have pegged Merck's potential liability at about $18 billion. Story
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
